DTIC-Dome (dacarbazine)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for DTIC-Dome (dacarbazine), covering 2026-04-15 to 2026-04-15. Get the full timeline:
Most recent: Clinical Trial Update: PET Adapted Brentuximab Vedotin and Pembrolizumab in Combination With Doxorubicin and Dacarbazine in Classic Hodgkin Lymphoma [Phase 2]